Navigation Links
Carrington Settles Lawsuit, Sets Sights On Future
Date:2/1/2008

IRVING, Texas, Feb. 1 /PRNewswire-FirstCall/ -- Carrington Laboratories, Inc. (OTC Bulletin Board: CARN) today announced the settlement of a lawsuit filed in February 2007 by Glamorpuss, Inc. The value of the settlement was not disclosed. Carrington maintains its position and denies any wrongdoing in the matter.

"We are eager to focus our full attention to analyzing our business and advancing DelSite's work with the bird flu vaccine, and needed to resolve some outstanding issues that occupied our time and resources at the corporate level," said Carlton E. Turner, PhD, Carrington's president and CEO. "We are glad to put this lawsuit behind us without significant financial impact."

DelSite Biotechnologies, Inc., is Carrington's wholly owned subsidiary that is developing its propriety GelSite(R) technology designed to provide controlled release of peptide and protein-based drugs and vaccines. DelSite is currently developing a nasal powder vaccine using its GelVac(TM) formula with the H5N1 avian flu antigen and conducting studies which are funded in part by two grants from the NIAID (National Institute of Allergy and Infectious Diseases) of NIH (National Institutes of Health) under the Department of Health and Human Services.

"This is a very exciting time for us," Dr. Turner said. "Last month DelSite announced the successful completion and results of preclinical toxicology studies of the GelVac(TM) nasal powder influenza vaccine under FDA-reviewed protocols. This clears our path to proceed to a Phase I clinical trial in humans later this year. We are, in fact, awaiting arrival of the H5N1 antigen and are fully prepared to manufacture the vaccine for clinical testing upon its arrival. This vaccine system, if successful, could very well revolutionize how vaccines are formulated, stored, distributed and administered."

"GelVac(TM) has been shown to work with many antigens," Dr. Turner continued. "It is stable at room temperature, requires
'/>"/>

SOURCE Carrington Laboratories, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related biology technology :

1. Carrington Announces Nasdaq Communication; Prepares for Shares to Be Quoted on the OTC Bulletin Board and Pink Sheets
2. Carrington Reports Second Quarter 2007 Results
3. Carrington Completes $8 Million Financing
4. Carrington Reports on ISO 9001:2000 Inspection at Sabila Industrial in Costa Rica
5. Carrington Subsidiary DelSite Biotechnologies Enters into Technology Evaluation Rights License Agreement for Transdermal Delivery of Vaccines
6. Carrington and DaySpring Pharma Extend and Formalize Agreement for Distribution of Diabetic and Radiation Products Into Physician Market
7. Carrington Laboratories Common Stock Now Trading on the OTC Bulletin Board: CARN.OB
8. Carrington Reports on ISO 9001:2000 Inspection
9. Carrington Reports Third Quarter 2007 Results
10. Carrington Retains Milkie/Ferguson to Explore Financial Alternatives
11. Discover Testing Settles the Drinking Water Debate: Tap vs. Bottled
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)MANILA, Philippines, Dec. 2 Spectrum Blue Steel is emerging as one of the fastest growing green energy companies on the planet. Through the efforts of True Green Energy Group and True Green Planet,s
(Date:12/2/2009)COPENHAGEN, Dec. 2 The world,s first concept demonstration tires made with BioIsoprene technology, a breakthrough alternative to replace a petrochemically produced ingredient in the manufacture of
(Date:12/2/2009)CAMBRIDGE, Mass., Dec. 2 TechConnect World, an event bringing together the leaders in technology development and product integration in cleantech, nanotech, biotech and MEMS, announced the December 1
(Date:12/2/2009)QUEBEC CITY, Dec. 2 /PRNewswire-FirstCall/ - AEterna Zentaris Inc. (NASDAQ: AEZS ; TSX: AEZ) (the "Company"), a global biopharmaceutical company focused on endocrine therapy and oncology, today annou
Breaking Biology Technology:Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 2Spectrum Blue Steel partners with Famous Chemists for Procuring Profitable Applications from Garbage Using the Biosphere MKV and Electrostatic Precipitators 3The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 2The World's First Goodyear Concept Tires Made with BioIsoprene(TM) Technology Arrive in Copenhagen in time for United Nations Climate Change Conference 3Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 2Deadline Approaching for Largest Commercialization Event for Nanotech & Clean Technologies 3AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 2AEterna Zentaris' Anti-Cancer Compound, Perifosine (KRX-0401), Receives FDA Fast Track Designation for the Treatment of Relapsed/Refractory Multiple Myeloma 3
...ronmental,Technologies, Inc. (OTC Bulletin Board: ...nce of its comprehensive livestock environmental,t...s., Anaerobic or methane digestion (AD) has been ...the late 1800s. While its efficiency has,improved ...process that,produces biogas (which generally cont...
...itories Event for the Pharmaceutical and ..., June 23 BioStorage Technologies, Inc., a,provid...e, sample,management and cold chain logistics, ann... for International Research,s (IIR) inaugural,Bior...e pharmaceutical and,biotech industries. Taking pl...
...y Commission funds formulation of two beverages wi...nologies., TORONTO, June 23 /PRNewswire-FirstCall...ormulation of two dairy beverages with GG-XT for A...e filed Canadian and International Patent Applicat...ns for GG-XT. GG-XT is a,proprietary compound of P...
Other Biology Technology:Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 2Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 3Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 4Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 5Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 6Bion Outlines Differences between its Patented Comprehensive Livestock Environmental Treatment Technology and Anaerobic Digesters 7BioStorage Technologies Announces Platinum Sponsorship of Biorepositories 2008 2Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 2Allegiance Equity Corporation announces collaboration with Canadian Dairy Commission and Guelph Food Technologies Corporation for Alzheimers and Dementia formulation GG-XT 3
(Date:12/4/2009)A major discovery is challenging accepted thinking about amyloids the fibrous protein deposits associated with diseases such as Alzheimer,s and Parkinson,s and may open up a potential new area for t
(Date:12/3/2009)Our ability to learn new information and adapt to changes in our daily environment, as well as to retain lifelong memories, appears to lie in the minute junctions where nerve cells communicate, accord
(Date:12/3/2009)Contents of this message: , , Preliminary Press Conference Topics, Last Call! Press Field Trip to California Academy of Sciences museum, Attention PIOs: Sending Press Releases to Fall meeting, N
Breaking Biology News(10 mins):New therapy targets for amyloid disease 2Lifelong memories linked to stable nerve connections 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 2AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 3AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 4AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 5AGU fall meeting: Preliminary press conference topics, press pre-registration deadline 6HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 1HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 2HCPC Calls for Greater Healthcare Savings Through Improved Adherence to Prescription Drug Regimens 4630 3Sofinnova Partners Leads Investment Round in CoAxia 49695 1Sofinnova Partners Leads Investment Round in CoAxia 49695 2Sofinnova Partners Leads Investment Round in CoAxia 49695 3CoAxia Inc Announces 2421 5M Series D Financing 4628 1CoAxia Inc Announces 2421 5M Series D Financing 4628 2CoAxia Inc Announces 2421 5M Series D Financing 4628 3
...ings, will she end up demented? These days, memory...nal which 70-year-olds risk developing dementia. T...ka Academy at the University of Gothenburg, Sweden...ct which elderly individuals risk developing demen...ws that memory loss is the only factor that can st...
...ity Belfast have discovered a new eco-friendly way...elp its transformation into popular products such ...ctor Rodrguez and Professor Robin Rogers from the ...neering worked along with The University of Alabam... energy efficient way of processing wood. , Thei...
...owth of institutional Memberships for open access ...announces the introduction of the "Online Reportin...embership accounts. Building on BioMed Central,s c... system will assist organizations, annual publicat...osts associated with managing open access publicat...
Other Biology News:Early identification of dementia increasingly difficult 2Queen's scientists discover eco-friendly wood dissolution 2
Rabbit Anti-ACAT-1 (H-125) Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
...ide-1(7-36) amide (GLP-1), C-terminal reactive. Cr...<0.1% cross reactivity with the unamidated forms G...es such as hGLP-2, glucagon, hGIP and VIP.,SPECI...identical in all mammalian species studied except ...
Anti-Lineage 1 (lin 1) Cocktail Monoclonal Antibody, FITC Conjugated from BD Biosciences - Immunocytometry Systems
Goat Anti-BAI-1 Polyclonal Antibody, Unconjugated from Santa Cruz Biotechnology, Inc.
Biology Products: